Navigation Links
RSB Spine, LLC Announces First Implantation of the InterPlate(TM) L for the Lumbar Spine
Date:1/16/2008

CLEVELAND, Jan. 16 /PRNewswire/ -- RSB Spine, LLC, today announced the first implantation of its proprietary InterPlate(TM) L in the lumbar spine. The InterPlate L was approved as an interbody device in September 2007. The unique design offers a number of advantages over current devices. In addition, RSB Spine has recently completed the national rollout of its InterPlate C device for use in the cervical spine, which is being very well received by spine surgeons across the United States. The company also expects to introduce two new InterPlate products manufactured from a radiolucent polymer (PEEK, polyetheretherketone) later this year.

Fusion is one of the most common spinal procedures performed by neurosurgeons and orthopedic spine surgeons. The InterPlate C and InterPlate L are designed to facilitate rapid fusion and are used in conjunction with graft material to fuse spinal vertebrae.

Robert S. Bray, Jr., M.D., the inventor of the InterPlate and the first to use the lumbar version, said: "The InterPlate L simplifies the implant procedure and provides a very low profile implant with secure anti-backout protection of the screws for safety under the great vessels. It is a next generation from anterior lumbar plates, with the versatility for all levels."

RSB Spine Chief Executive Officer John A. Redmond said: "Today's announcement marks yet another milestone for our InterPlate family of products. Featuring a one-of-a-kind design and ease of insertion, the InterPlate L is expected to be highly attractive to many spine surgeons, as well as very competitive with other devices currently in the marketplace."

Redmond continued: "The InterPlate L has been exhibited at a number of spine meetings and the response has been gratifying, with many surgeons anxious to utilize this new device when released nationally."

RSB Spine is a privately held medical device company focused on developing innovative spinal implants. In 2004, RSB Spine s
'/>"/>

SOURCE RSB Spine, LLC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... NJ (PRWEB) January 22, 2015 ... technologies such as the Bioruptor® and complete solutions ... system for chromatin immunoprecipitation, alleviating the need for ... and controls needed for ChIP of histones or ...
(Date:1/22/2015)...   GenoSpace , a precision medicine software company that has ... use of genomic, imaging and other biomedical data in research ... Munson , CEO of Aspera, an IBM Company, to its ... http://photos.prnewswire.com/prnh/20150122/170713 "We are pleased to welcome ...
(Date:12/24/2014)... DALLAS and NEW YORK , ... a biopharmaceutical company advancing patient care in critical areas, announced ... of common stock, and warrants to purchase up to an ... of $4.00 per share and $.01 per warrant.  The warrants ...
(Date:12/24/2014)... Louis, Missouri (PRWEB) December 23, 2014 GMO ... biotechnology company, Syngenta, are in the process of being consolidated ... case is In Re: Syngenta AG MIR 162 Corn Litigation, ... District of Kansas. , Management of the Syngenta GMO corn ...
Breaking Biology Technology:Diagenode Launches Unique Semi-Automated Solution for Chromatin Immunoprecipitation 2GenoSpace Expands Board with Appointment of Michelle Munson 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 3Carey Danis & Lowe Reports on Syngenta GMO Corn Transfer Order 2
... , , -- Phase III ... cancer and non-small cell lung cancer, expected to begin ... strengthens Teva,s oncology offerings with novel therapeutic designed to ... BOTHELL, WA and VANCOUVER, Canada, Dec. 21 /PRNewswire-FirstCall/ - ...
... CHAMPAIGN, Ill. Imagine a polka-dotted postage stamp that can ... colors. As reported in the Sept. 13 issue of ... team at the University of Illinois have developed an artificial ... that is simple, fast and inexpensive and works by ...
... Signatec Inc. today ... The PX1500-4 captures four synchronized channels at sampling rates up to 1.5 GHz, or ... , ... 18, 2009 -- Signatec Inc. today announced the PX1500-4 high-speed digitizer, the most ...
Cached Biology Technology:Teva Expands Innovative Pipeline with License Agreement to Develop and Commercialize OncoGenex' Late Stage Innovative Treatment for Multiple Oncology Indications 2Teva Expands Innovative Pipeline with License Agreement to Develop and Commercialize OncoGenex' Late Stage Innovative Treatment for Multiple Oncology Indications 3Teva Expands Innovative Pipeline with License Agreement to Develop and Commercialize OncoGenex' Late Stage Innovative Treatment for Multiple Oncology Indications 4Teva Expands Innovative Pipeline with License Agreement to Develop and Commercialize OncoGenex' Late Stage Innovative Treatment for Multiple Oncology Indications 5Teva Expands Innovative Pipeline with License Agreement to Develop and Commercialize OncoGenex' Late Stage Innovative Treatment for Multiple Oncology Indications 6Teva Expands Innovative Pipeline with License Agreement to Develop and Commercialize OncoGenex' Late Stage Innovative Treatment for Multiple Oncology Indications 7Teva Expands Innovative Pipeline with License Agreement to Develop and Commercialize OncoGenex' Late Stage Innovative Treatment for Multiple Oncology Indications 8Opto-electronic nose sniffs out toxic gases 2Opto-electronic nose sniffs out toxic gases 3Signatec Releases PX1500-4, Its 4-Channel, 1.5 GHz Per Channel / 2-Channel, 3 GHz Per Channel PCI-Express Digitizer with Two Virtex-5 FPGAs 2Signatec Releases PX1500-4, Its 4-Channel, 1.5 GHz Per Channel / 2-Channel, 3 GHz Per Channel PCI-Express Digitizer with Two Virtex-5 FPGAs 3Signatec Releases PX1500-4, Its 4-Channel, 1.5 GHz Per Channel / 2-Channel, 3 GHz Per Channel PCI-Express Digitizer with Two Virtex-5 FPGAs 4
(Date:1/22/2015)... YORK and POINT ROBERTS, Washington ... news source covering leading sectors including technology and tech stocks, ... Privacy marketplace featuring master pickpocket and security consultant Apollo ... is stolen and talks about the Wocket™ biometric smart wallet, ...
(Date:1/22/2015)... Research and Markets ( http://www.researchandmarkets.com/research/wxdglm/global_wearable ) ... Wearable Technologies Market and Applications, Opportunities, Industry Analysis, ... 2014-2020" report to their offering. , ... can be worn on the user,s body and ...
(Date:12/24/2014)... YORK , Dec. 23, 2014  Since its launch in December ... people to eliminate the pain of trying to remember their ... own biometrics fused to their smartphones. To assist people who ... , the company that created 1U and focuses on redefining ...
Breaking Biology News(10 mins):Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 2Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 3Global Wearable Technologies Market and Applications, Opportunities, Industry Analysis, Segmentation, Size, Growth, Share, Overview, Trends and Forecast 2014-2020 21U Offers Best Solution to the Username / Password Dilemma: For FREE! 21U Offers Best Solution to the Username / Password Dilemma: For FREE! 3
... HOUSTON -- (June 10, 2010) Most of ... dormant, with just a few producing blood cells and ... invading bacteria can be a call-to-arms, awaking the sleeping ... cells that fight the foreign organisms. The "bugler" that ...
... to most forms of life, and occurs naturally in soil ... exposure to arsenic has been linked to lung, bladder and ... levels or arsenic in drinking water. Chemically similar to phosphorus, ... resembles phosphate (PO 4 3- ). Arsenate interferes with ...
... (KINGSTON, ON.) Queen,s University Brian Amsden is hoping that ... valve will be able to regenerate itself after an injury ... from the University of Western Ontario and University of Toronto, ... rebuild human tissue and speed the healing process. , While ...
Cached Biology News:Gamma interferon a wake-up call for stem cell response to infection 2Gamma interferon a wake-up call for stem cell response to infection 3Arsenic hyperaccumulating ferns: How do they survive? 2Arsenic hyperaccumulating ferns: How do they survive? 3
... a silica based spin filter membrane to isolate ... DNA band is cut from an agarose gel ... The gel slice is melted irreversibly in a ... bound to the silica spin filter membrane and ...
...
... Application: The greater incorporation of Br-dUTP results ... when detected using a fluorescein-labeled anti-BrdU antibody. ... in the kit to counterstain the total ... Br-dUTP, resulting in improved detection than found ...
Mouse polyclonal antibody raised against a partial recombinant WRB. NCBI Entrez Gene ID = 7485...
Biology Products: